Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients

Annals of Surgery

Volumn 221, Issue 6, 1995, Pages 721-733

  Yeo, Charles J ^a,b   Cameron, John L ^a   Lillemoe, Keith D ^a   Sitzmann, James V ^a   Hruban, Ralph H ^a   Goodman, Steven N ^a   Dooley, William C ^a   Coleman, JoAnn ^a   Pitt, Henry A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; DIPLOIDY; DNA CONTENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0029002348     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199506000-00011     Document Type: Article

References (48)

1. Steele GD Jr, Osteen RT, Winchester DP, et al. Clinical highlights from the National Cancer Data Base: 1994. Ca Cancer J Clin 1994; 44:71-80.
2. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality and survival after the Whipple procedure. Ann Surg 1987; 206:358-365.
3. Trede M. The surgical treatment of pancreatic carcinoma. Surgery 1985; 97:28-35.
4. Delcore R, Thomas JH, Hermreck AS. Pancreaticoduodenectomy for malignant pancreatic and periampullary neoplasms in elderly patients. Am J Surg 1991; 162:532-536.
5. Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and forty-five consecutive pancreatieoduodencctomies without mortality. Ann Surg 1993; 217:430-438.
6. Gordon TA, Burleyson GP, Tielsch JM, et al. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 1995; 221:43-49.
7. Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161:120-125.
8. Trede M, Schwall G, Saeger H. Survival after pancreaticoduodenectomy. Ann Surg 1990; 211:447-458.
9. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993; 165:68-73.
10. Willett CG, Lewandrowski K, Warshaw AL, et al. Resection margins in carcinoma of the head of the pancreas: implications for radiation therapy. Ann Surg 1993; 217:144-148.
11. Allison DC, Bose KK, Hruhan RH, et al. Pancreatic cancer cell DNA content correlates with long-term survival after pancreaticoduodenectomy. Ann Surg 1991; 214:648-656.
12. Seymour AB, Hruban RH, Redston M, et al. Allelotype of pancreatic carcinoma. Cancer Res 1994; 54:2761-2764.
13. Redston MS, Caldas C, Seymour AB, et al. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdelctions. Cancer Res 1994; 54: 3025-3033.
14. Yeo CJ, Hruban RH, Kern SE, et al. Adenocarcinoma of the pancreas: factors influencing outcome following pancreaticoduodenectomy - The Johns Hopkins experience. Cancer Bull 1994; 46: 504-510.
15. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
16. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-220.
17. Tsuchiya R, Tomioka T, Izawa K, et al. Collective review of small carcinomas of the pancreas. Ann Surg 1986; 203:77-81.
18. Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120:899-903.
19. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987; 59:2006-2010.
20. Crile G Jr. The advantages of bypass operations over radical pancreaticoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970; 130:1049-1053.
21. Shapiro TM. Adenocarcinoma of the pancreas: a statistical analysis of bypass vs. Whipple resection in good risk patients. Ann Surg 1975; 182:715-721.
22. Kellum JM, Clark J, Miller HH. Pancreatoduodenectomy for resectable malignant periampullary tumors. Surg Gynecol Obstet 1983; 157:362-366.
23. Ozaki H. Retrospective study of resectable pancreatic cancer: results of cases collected from 12 institutions. Pancreas 1994; 9:414-415.
24. Fortner JG. Regional pancreatectomy for cancer of the pancreas, ampulla and other related sites. Ann Surg 1984; 199:418-425.
25. Manabe T, Ohshio G, Baba N, et al. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 1989; 64: 1132-1137.
26. Sindclar WF. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 1989; 124:127-132.
27. Yeo CJ, Cameron JL. Arguments against radical (extended) resection for adenocarcinoma of the pancreas. Adv Surg 1994; 27:273-284.
28. 1 carcinoma of the pancreas. Surg Gynecol Obstet 1992; 175:259-265.
29. Grace PA, Pitt HA, Longmire WP. Pylorus-preserving pancreatoduodenectomy: an overview. Br J Surg 1990; 77:968-974.
30. Belli L, Riolo F, Romani F, et al. Pylorus-preserving pancreatoduodenectomy versus Whipple procedure for adenocarcinoma of the head of the pancreas. HPB Surgery 1989; 1:195-200.
31. Sharp KW, Ross CB, Halter SA, et al. Pancreatoduodenectomy with pyloric preservation for carcinoma of the pancreas: a cautionary note. Surgery 1989; 105:645-653.
32. Roder JD, Stein HJ, Huttl W, et al. Pylorus-preserving versus standard pancreaticoduodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg 1992; 79:152-155.
33. Takada T, Yasuda H, Shikata JI, et al. Postprandial plasma gastrin and secretin concentrations after a Pancreatoduodenectomy. Ann Surg 1989; 210:47-51.
34. Williamson RCN, Bliouras N, Cooper MJ, et al. Gastric emptying and enterogastric reflux after conservative and conventional pancreatoduodenectomy. Surgery 1993; 114:82-86.
35. Bose KK, Allison DC, Hruban RH, et al. A comparison of flow cytometric and absorption cytometric DNA values as prognostic indicators for pancreatic carcinoma. Cancer 1993; 71:691-700.
36. Bottger TC, Storkel S, Wellek S, et al. Factors influencing survival after resection of pancreatic cancer: a DNA analysis and a histomorphologic study. Cancer 1994; 73:63-73.
37. Herrera MF, van Heerden JA, Katzmann JA, et al. Evaluation of DNA nuclear pattern as a prognostic determinant in resected pancreatic ductal adenocarcinoma. Ann Surg 1992; 215:120-124.
38. Tashiro S, Uchino R, Hiraoka T, et al. Surgical indication and significance of portal vein resection in biliary and pancreatic cancer. Surgery 1991; 109:481-487.
39. Cusack JC, Fuhrman GM, Lee JE, et al. Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. Am J Surg 1994; 168:352-354.
40. Jessup JM, Steele G Jr, Mayer RJ, et al. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993; 128: 559-564.
41. Yeung RS, Weese JL, Hoffman JP, et al. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma: a phase II study. Cancer 1993; 72:2124-2133.
42. Ishikawa O, Ohigashi H, Imaoka S, et al. Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Arch Surg 1994; 129:1075-1080.
43. Evans DB, Termuhlen PM, Byrd DR, et al. Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg 1993; 218:54-60.
44. Burrows L and Tartter P. Effect of blood transfusion on colonic malignancy recurrence rate. Lancet 1982; 2:662.
45. Crowe JP, Gordan NH, Fry DE, et al. Breast cancer survival and perioperative blood transfusion. Surgery 1989; 106:836-841.
46. Wu H, Little A. Perioperative blood transfusions and cancer recurrence. J Clin Oncol 1988; 6:1348-1354.
47. Caldas C, Hahn SA, daCosta L, et al. Frequent somatic mutations and homozygous deletions of the MTS1 gene in pancreatic adenocarcinoma. Nature Genet 1994; 8:27-32.
48. Caldas C, Hahn SA, Hruban RH, et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal mucinouscell hyperplasia. Cancer Res 1994; 54: 3568-3573.